File(s) under permanent embargo
Transgenic swine: expression of human CD39 protects against myocardial injury
journal contribution
posted on 2012-05-01, 00:00 authored by Debra G Wheeler, Matthew E Joseph, Shouvik D Mahamud, William L Aurand, Peter J Mohler, Vincent J Pompili, Karen DwyerKaren Dwyer, Mark B Nottle, Sharon J Harrison, Anthony J F d'Apice, Simon C Robson, Peter J Cowan, Richard J GuminaUNLABELLED: CD39 (ectonucleoside triphosphate diphosphohydrolase-1; ENTPD-1) rapidly hydrolyzes ATP and ADP to AMP; AMP is hydrolyzed by ecto-5'-nucleotidase (CD73) to adenosine, an anti-thrombotic and cardiovascular protective mediator. While expression of human CD39 in a murine model of myocardial ischemia/reperfusion (I/R) injury confers cardiac protection, the translational therapeutic potential of these findings requires further testing in a large animal model. To determine if transgenic expression of CD39 reduces infarct size in a swine model of myocardial ischemia/reperfusion injury, transgenic pigs expressing human CD39 (hCD39) were generated via somatic cell nuclear transfer and characterized. Expression of hC39 in cardiac tissue was confirmed by immunoblot and immunohistochemistry. Myocardial I/R injury was induced by intracoronary balloon inflation in the left anterior descending (LAD) artery for 60 min followed by 3 hours of reperfusion. The ischemic area was delineated by perfusion with 5% phthalo blue and the myocardial infarct size was determined by triphenyl tetrazolium chloride (TTC) staining. During ischemia, the rate-pressure product was significantly lower in control versus hCD39-Tg swine. Following reperfusion, compared to littermate control swine, hCD39-Tg animals displayed a significant reduction in infarct size (hCD39-Tg: 17.2 ± 4.3% vs. CONTROL: 44.7 ± 5.2%, P=0.0025). Our findings demonstrate for the first time that the findings in transgenic mouse models translate to large animal transgenic models and validate the potential to translate CD39 into the clinical arena to attenuate human myocardial ischemia/reperfusion injury.
History
Journal
Journal of molecular and cellular cardiologyVolume
52Issue
5Pagination
958 - 961Publisher
ElsevierLocation
Amsterdam, The NetherlandsPublisher DOI
eISSN
1095-8584Language
engPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2012, ElsevierUsage metrics
Categories
No categories selectedKeywords
AnimalsAnimals, Genetically ModifiedAntigens, CDApyraseBlood PressureCoronary VesselsHeart RateHeart VentriclesHumansIschemiaMyocardial Reperfusion InjuryPromoter Regions, GeneticRecombinant ProteinsSwineScience & TechnologyLife Sciences & BiomedicineCardiac & Cardiovascular SystemsCell BiologyCardiovascular System & CardiologyTransgenic pigEctonucleoside triphosphate diphosphohydrolase 1CD39Myocardial ischemiaReperfusionECTONUCLEOTIDASESTRANSPLANTATIONRECEPTORSDISEASEMICE
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC